Pertussis Market Review: Emerging Opportunities, Competitive Landscape, and Pipeline

Pertussis Market: Trends, Therapeutics, and Future Outlook

The Pertussis Market is projected to witness steady growth over the coming years, fueled by increasing awareness of the disease and the development of more effective interventions. As the global healthcare ecosystem intensifies efforts to combat pertussis, innovative vaccines and advanced treatment options are driving the Pertussis Drugs Market forward. Key Pertussis Companies leading this progress include Serum Institute of India, LG Chem, ILiAD Biotechnologies, Dynavax Technologies, Tianjin CanSino Biotechnology, Faron Pharmaceuticals, Kymab, BioNet, and several others.

Market Insights and Scope

According to DelveInsight’s report, “Pertussis Market Insights, Epidemiology, and Market Forecast – 2034”, the Pertussis Treatment Market is analyzed comprehensively across the United States, EU4 (Germany, France, Italy, Spain), the United Kingdom, and Japan. Covering historical trends, current treatment patterns, emerging therapies, and competitive dynamics, the report offers insights into the Pertussis Market Size from 2020–2034, with detailed forecasts for 2024–2034. The study also evaluates segmentation by therapy and drug class, providing stakeholders with strategic intelligence to make informed decisions.

Understanding Pertussis: Disease and Diagnosis

Pertussis, commonly known as whooping cough, is a severe respiratory infection caused by Bordetella pertussis. The disease progresses through three stages: catarrhal, paroxysmal, and convalescent. Accurate diagnosis can be challenging, involving culture, PCR, paired sera, and single sera tests, with paired sera tests considered the most reliable.

Prevention and Treatment

Vaccination remains the cornerstone of pertussis prevention. In the U.S., DTaP and Tdap vaccines are widely administered, with all adolescents and adults recommended to receive at least three doses. The Pertussis Therapeutics Market primarily relies on macrolide antibiotics, including erythromycin, clarithromycin, and azithromycin, though side effects may sometimes limit adherence. Supportive care, including oxygen therapy, hydration, and avoidance of respiratory irritants, is also critical.

Epidemiology and Market Size

In 2022, approximately 19 million individuals were vaccinated in the U.S., with 5 million adults receiving booster doses. Across the seven major markets (7MM), around 34 million people received vaccines. This number is projected to grow, driven by increased awareness, updated immunization guidelines, and innovative vaccine introductions. The Pertussis Treatment Market Size in the 7MM was $3.5 billion in 2022, with the U.S. representing the largest share.

Vaccine Landscape and Emerging Therapies

• ADACEL (Sanofi Pasteur): Trivalent booster available in 55 countries.
  
  
• BOOSTRIX (GSK): Recommended for individuals aged 10 and above, including maternal immunization programs.
  
  

Emerging vaccines include:

• BPZE1 (ILiAD Biotechnologies): Intranasal booster in Phase IIb with FDA Fast Track designation.
  
  
• BK1310/MT-2355 (Mitsubishi Tanabe Pharma): 5-in-1 combination vaccine planned for launch in Japan.
  
  

Market Outlook

Complete immunization is crucial to controlling pertussis. While infant and childhood vaccination rates are high, adult booster compliance remains low. The Pertussis Market is highly competitive, particularly in the U.S. and Europe, with vaccines such as PEDIARIX, PENTACEL, and Vaxelis shaping market dynamics, while Mitsubishi leads in Japan with TETRABIK.

Reimbursement, Uptake, and Competitive Intelligence

The report evaluates reimbursement scenarios, adoption rates for new vaccines, patient uptake trends, and sales performance. It also provides insights into pipeline developments, collaborations, patent filings, and regulatory progress. Insights from key opinion leaders across the 7MM validate current and emerging treatments, ensuring that stakeholders understand market opportunities and challenges.

The Pertussis Therapeutics Market continues to evolve with novel vaccines and treatment approaches, positioning it as a dynamic and growing segment in the global pharmaceutical landscape.
Latest Reports
Acute Pyelonephritis Market | Asperger Syndrome Market | Attention Deficit Hyperactivity Disorder Adhd Market | Cardiopulmonary Management Device Market | Childhood Atropine For Myopia Progression Market | Cholangiocarcinoma Market | Dyspepsia Market | Emphysema Market | Genital Herpes Market | Growth Hormone Deficiency Market | Guillain-barré Syndrome Market | Hairy Cell Leukemia Market | Intestinal Obstruction Market | Malignant Fibrous Histiocytoma Market | Menopause Market | Metabolic Acidosis Market | Multiple Myeloma Market | Neurostimulation Devices Market